OpenLLM-France/wikimedia huggingface dataset:
# Pinyin/Wish

to wish: to want something, or to want to do something
xiwahng: xiaangyaoh huoh xiaaang zuoh mooushihhwuh
a wish: a feeling that you want something or want to do something
yuahnwahng: xiaangyaoh huoh xiaaang zuoh mooushihhwuh d xiaangfaa
# Pokémon/Pokédex/Froslass
## Base Statistics

A Ice and Ghost type Pokémon.

## Type Matching

Moves that deal 200% of their damage to Froslass: fire, fighting, rock, steel, ghost, dark Moves that deal 50% of their damage to Froslass: ice, bug Moves that deal 0% of their damage to Froslass: normal, fighting

## How to Evolve

Evolves from female Snorunt when given a stone.

## Name

Contains the word "lass".
# Pokémon/Pokédex/Frosmoth
## Description

A snow white mothlike Pokémon.

## Base Statistics

A Ice and Bug type Pokémon.

## Type Matching

Moves that deal 400% of their damage to Frosmoth: fire, rock Moves that deal 200% of their damage to Frosmoth: steel, flying Moves that deal 50% of their damage to Frosmoth: ice, grass, ground
# Pokémon/Pokédex/Furret

National Pokédex:

## Basic Statistics

* National Index: 162
* Johto Index: 20
* Hoenn Index: 317
* Stage: Stage 1
* Height: 1.8m/5'11"
* Weight: 32.5kg/72.0lb
* Gender Distribution: 50% Male
* Ability: Run Away/Keen Eye
* Type: Normal
* Species: Long Body
* Egg Group: Ground
* Hatch Steps: 3840
* Catch Rate: 90
* Base Experience: 116
* Max Experience: 1000000
* Hold Item in Advance: Oran Berry (50%) & Sitrus Berry(5%)
| | HP | Attack | Defense | Speed | Special Attack | Special Defense |
| Base Stats (RB/Y) | - | - | - | - | - | - |
| Base Stats (GS/C) | 85 | 76 | 64 | 90 | 45 | 55 |
| Base Stats (RS/FL/E) | 85 | 76 | 64 | 90 | 45 | 55 |
| Base Stats (DP/PT/HGSS) | – | – | – | – | – | – |
| Base Stats (BW/B2W2) | – | – | – | – | – | – |
| Base Stats (XY/ORAS) | – | – | – | – | – | – |
| Base Stats (SM/USUM) | – | – | – | – | – | – |
| Base Stats (Sword/Shield/BDSP) | – | – | – | – | – | – |
| Max Stats (RB/Y) | - | - | - | - | - | - |
| Max Stats (GS/C) | 373 | 250 | 226 | 278 | 188 | 208 |
| Max Stats (RS/FL/E) | 374 | 276 | 249 | 306 | 207 | 229 |
| Max Stats (DP/PT/HGSS) | – | – | – | – | – | – |
| Max Stats (B/W/B2W2) | – | – | – | – | – | – |
| Max Stats (X/Y/ORAS) | – | – | – | – | – | – |
| Max Stats (SM/USUM) | – | – | – | – | – | – |
| Max Stats (Sword/Shield/BDSP) | – | – | – | – | – | – |
| Effort Points (Sword/Shield/BDSP) | – | – | – | – | – | – |

## Type Matching

Move types which are good on Furret: Fighting Move types which don't effect Furret: Ghost
All other move types are normal effectiveness on Furret.

## Moveset

| Level | Gold / Silver | Crystal | Ruby / Sapphire Emerald XD / Colosseum | Fire Red / Leaf Green |
| Start | Scratch Defense Curl Quick Attack | Scratch Defense Curl Quick Attack | Scratch Defense Curl Quick Attack | Scratch Defense Curl Quick Attack |
| 4 | - | - | Defense Curl | Defense Curl |
| 5 | Defense Curl | Defense Curl | - | - |
| 7 | - | - | Quick Attack | Quick Attack |
| 11 | Quick Attack | Quick Attack | - | - |
| 12 | - | - | Fury Swipes | Fury Swipes |
| 18 | Fury Swipes | Fury Swipes | - | - |
| 19 | - | - | Helping Hand | Helping Hand |
| 28 | Slam | Slam | Slam | Slam |
| 37 | - | - | Follow Me | Follow Me |
| 38 | Rest | Rest | - | - |
| 48 | Amnesia | Amnesia | Rest | Rest |
| 59 | - | - | Amnesia | Amnesia |

### TM/HM

* GS/C/RS/FL: Attract, Cut, Dig, Double Team, Frustration, Hidden Power, Hyper Beam, Iron Tail, Protect, Rest, Return, Shadow Ball, Strength, Sunny Day, Surf, Thief, Toxic
* GS/C: Curse, Defense Curl, Detect, Dynamicpunch, Endure, Fire Punch, Fury Cutter, Headbutt, Ice Punch, Mud-Slap, Rollout, Sleep Talk, Snore, Swagger, Swift, Thunderpunch
* RS/FL: Blizzard, Brick Break, Facade, Flamethrower, Focus Punch, Ice Beam, Rain Dance, Rock Smash, Secret Power, Shock Wave, Solarbeam, Thunder, Thunderbolt, Water Pulse

### Evolution

* GS/C/RS/FL: Double-Edge, Focus Energy, Pursuit, Reversal, Slash
* RS/FL: Assist, Substitute, Trick

## Trading Cards

* Neo Genesis #35 - Furret
* Aquapolis #48 - Furret
* EX Team Rocket Returns #22 - Furret
| Basic: Sentret | Stage 1: Furret | (No Stage 2) |
# Pokémon/Pokédex/Gallade
## Description

A bipedal pokémon.

## Base Statistics

A Psychic and Fighting type Pokémon.

## Type Matching

Moves that deal 200% of their damage to Gallade: ghost, flying, fairy Moves that deal 50% of their damage to Gallade: fighting, rock

## How to Evolve

Gallade can evolve from male Kirlia.
# Pokémon/Pokédex/Fuecoco
## Description

A red crocodile like Pokémon.

## Base Statistics

A fire type Pokémon.
| | HP | Attack | Defense | Speed | Special Attack | Special Defense |
| Base Stats (RB/Y) | – | – | – | – | – | – |
| Base Stats (GS/C) | – | – | – | – | – | – |
| Base Stats (RS/FL/E) | – | – | – | – | – | – |
| Base Stats (DP/PT/HGSS) | – | – | – | – | – | – |
| Base Stats (BW/B2W2) | – | – | – | – | – | – |
| Base Stats (XY/ORAS) | – | – | – | – | – | – |
| Base Stats (SM/USUM) | – | – | – | – | – | – |
| Base Stats (Sword/Shield/BDSP) | – | – | – | – | – | – |
| Max Stats (RB/Y) | – | – | – | – | – | – |
| Max Stats (GS/C) | – | – | – | – | – | – |
| Max Stats (RS/FL/E) | – | – | – | – | – | – |
| Max Stats (DP/PT/HGSS) | – | – | – | – | – | – |
| Max Stats (B/W/B2W2) | – | – | – | – | – | – |
| Max Stats (X/Y/ORAS) | – | – | – | – | – | – |
| Max Stats (SM/USUM) | – | – | – | – | – | – |
| Max Stats (Sword/Shield/BDSP) | – | – | – | – | – | – |
| Effort Points (Sword/Shield/BDSP) | – | – | – | – | – | – |

## Type Matching

Moves that deal 200% of their damage to Fuecoco: water, ground, rock Moves that deal 50% of their damage to Fuecoco: fire, grass, ice, bug, steel, fairy

## How to Evolve

It evolves into Crocalor

## Notes

Introduced in Pokémon Scarlet and Violet, where is serves as a starter. Notably, it is quite strong against two of the gyms closest to the starting location, making it quite strong in the early game.
# Pokémon/Pokédex/Frigibax
## Description

A tiny bipedal dragon.

## Base Statistics

A dragon and ice type Pokémon.

## Type Matching

Moves that deal 200% of their damage to Frigibax: dragon, fairy, fighting, rock, steel Moves that deal 50% of their damage to Frigibax: water, grass, electric

## How to Evolve

Evolves into Arctibax.
# Pokémon/Pokédex/Gabite
## Description

A bipedal sharklike pokémon.

## Base Statistics

A Dragon and Ground type Pokémon.

## Type Matching

Moves that deal 400% of their damage to Gabite: ice Moves that deal 200% of their damage to Gabite: dragon, fairy Moves that deal 50% of their damage to Gabite: fire, electric, poison, rock Moves that deal 0% of their damage to Gabite: electric

## How to Evolve

Gabite evolves from Gible, and evolves into Garchomp.
# Pokémon/Pokédex/Garchomp
## Description

A bipedal sharklike pokémon.

## Base Statistics

A Dragon and Ground type Pokémon.

## Type Matching

Moves that deal 400% of their damage to Garchomp: ice Moves that deal 200% of their damage to Garchomp: dragon, fairy Moves that deal 50% of their damage to Garchomp: fire, electric, poison, rock Moves that deal 0% of their damage to Garchomp: electric

## How to Evolve

Garchomp evolves from Gabite.
# Pokémon/Pokédex/Gardevoir
## Basic Statistics

* National Index: 282
* Johto Index: 282
* Hoenn Index: 31
* Stage: Stage 2
* Height: 1.6m/5'3"
* Weight: 48.4kg/107.0lb
* Gender Distribution: 50% Male
* Ability: Synchronize/Trace
* Type: Psychic
* Species: Embrace
* Egg Group: Indeterminate
* Hatch Steps: 5120
* Catch Rate: 45
* Base Experience: 208
* Max Experience: 1250000
| | HP | Attack | Defense | Speed | Special Attack | Special Defense |
| Base Stats (RB/Y) | - | - | - | - | - | - |
| Base Stats (GS/C) | - | - | - | - | - | - |
| Base Stats (RS/FL/E) | 68 | 65 | 65 | 80 | 125 | 115 |
| Base Stats (DP/PT/HGSS) | – | – | – | – | – | – |
| Base Stats (BW/B2W2) | – | – | – | – | – | – |
| Base Stats (XY/ORAS) | – | – | – | – | – | – |
| Base Stats (SM/USUM) | – | – | – | – | – | – |
| Base Stats (Sword/Shield/BDSP) | – | – | – | – | – | – |
| Max Stats (RB/Y) | - | - | - | - | - | - |
| Max Stats (GS/C) | - | - | - | - | - | - |
| Max Stats (RS/FL/E) | 340 | 251 | 251 | 284 | 383 | 361 |
| Max Stats (DP/PT/HGSS) | – | – | – | – | – | – |
| Max Stats (B/W/B2W2) | – | – | – | – | – | – |
| Max Stats (X/Y/ORAS) | – | – | – | – | – | – |
| Max Stats (SM/USUM) | – | – | – | – | – | – |
| Max Stats (Sword/Shield/BDSP) | – | – | – | – | – | – |
| Effort Points (Sword/Shield/BDSP) | – | – | – | – | – | – |

## Type Matching

Move types which are good on Gardevoir: Bug, Dark;, Ghost; Move types which are bad on Gardevoir: Fighting, Psychic
All other move types are normal effectiveness on Gardevoir.

## How to Get

Gardevoir can only be caught by evolving Kirlia at Level 30.

## Moveset

| Level | Ruby / Sapphire | Fire Red / Leaf Green |
| Start | Growl Confusion Double Team Teleport | Growl Confusion Double Team Teleport |
| 6 | Confusion | Confusion |
| 11 | Double Team | Double Team |
| 16 | Teleport | Teleport |
| 21 | Calm Mind | Calm Mind |
| 26 | Psychic | Psychic |
| 33 | Imprison | Imprison |
| 42 | Future Sight | Future Sight |
| 51 | Hypnosis | Hypnosis |
| 60 | Dream Eater | Dream Eater |

### TM/HM

* RS/FL: Attract, Calm Mind, Double Team, Facade, Flash, Frustration, Hidden Power, Hyper Beam, Light Screen, Protect, Psychic, Rain Dance, Reflect, Rest, Return, Safeguard, Secret Power, Shadow Ball, Shock Wave, Skill Swap, Snatch, Sunny Day, Taunt, Thief, Thunderbolt, Torment, Toxic

### Evolution

* RS/FL: Destiny Bond, Disable, Mean Look, Memento, Will-O-Wisp

## Trading Cards

* EX Ruby & Sapphire #7 - Gardevoir
* EX Sandstorm #96 - Gardevoir EX
| Basic: Ralts | Stage 1: Kirlia | Stage 2: Gardevoir |
| Basic: Ralts | Stage 1: Kirlia | Stage 2: Gallade |
# Radiation Oncology/Supportive care/Hyperbaric

* Front Page: Radiation Oncology | RTOG Trials | Randomized Trials
Hyperbaric Oxygen

## Acute RT Toxicity

* Erasmus University Medical Center (2006-2007) -- RT +/- HBO
** Randomized. Trial stopped prematurely due to slow accrual and lack of financial support. 19 of expected 132 patients, oropharynx or nasopharynx. Standard RT, then Arm 1) HBO vs. Arm 2) control. HBO given in 30 sessions @ 2.5 ATA x 90 minutes, started within 2 days after RT completion
** 2009 PMID 19386439 -- "Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer." (Teguh DN, Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):711-6. Epub 2009 Apr 20.)
*** Outcome: Significant improvement in QoL for HBO, particularly swallowing, stickly saliva, xerostomia, and pain in mouth
*** Conclusion: HBO after RT results in better quality of life

## Osteoradionecrosis

* French Multi-Institutional (1997-2001) -- hyperbaric oxygen vs. placebo
** Randomized. Stopped early after 2nd interim analysis for lower HBO outcomes. 68 patients, history of RT for H&N cancer, with overt mandibular radionecrosis. Severe forms such as mandibular fracture or bony resorption excluded. Arm 1) 30 HBO exposures @ 2.4 ATM x90 min prior to surgery, with additional 10 HBO exposures post-operatively vs. Arm 2) placebo
** 2004 PMID 15520052 -- "Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group." (Annane D, J Clin Oncol. 2004 Dec 15;22(24):4893-900. Epub 2004 Nov 1.)
*** Outcome: 1-year recovery HBO 19% vs. placebo 32% (NS)
*** Conclusion: Patients with overt mandibular osteoradionecrosis didn't benefit from HBO
** Comment (PMID 16119304): Suboptimal surgery, therefore results not surprising. Principles as follows: 1) Deliver majority of HBO prior to surgery, 2) Eradicate all non-viable bone, 3) Optimize surgical technique. This was not done properly in trial
* University of Miami -- hyperbaric oxygen vs. penicillin
** Randomized. High risk patients, history of RT >60 Gy to mandible, who required tooth removal, no persistent tumor. Arm 1) hyperbaric oxygen 20 sessions @ 2.4 ATA x90 minutes prior to extraction, followed by 10 additional sessions after vs. Arm 2) penicillin 1 million units
** 1985 PMID 3897335 -- "Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin." (Marx RE, J Am Dent Assoc. 1985 Jul;111(1):49-54.)
*** Outcome: incidence of ORN: HBO 5% vs. penicillin 30% (SS)
*** Conclusion: HBO should be considered a prophylactic measure when post-RT dental care involving trauma to tissue is necessary
# Radiation Oncology/Supportive care/Libido

* Front Page: Radiation Oncology | RTOG Trials | Randomized Trials
Libido

## Women: Testosterone Replacement

* NCCTG N02C3 (2004-2005)
** Randomized, cross-over. 150 postmenopausal women, history of cancer but NED, reported decrease in sexual desire, and a sexual partner. None on hormone replacement. Arm 1) 2% testosterone in Vanicream for 10 mg/day x4 weeks vs. Arm 2) placebo Vanicream, then crossed over for additional 4 weeks. Primary endpoint sexual desire/libido assessed at 4 and 8 weeks
** 2007 PMID 17470735 -- "Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3." (Barton DL, J Natl Cancer Inst. 2007 May 2;99(9):672-9.
*** Outcome: mean testosterone significantly increased, but average libido change no different
*** Conclusion: No benefit, possibly because women on study were estrogen depleted
# Radiation Oncology/Supportive care/General

* Front Page: Radiation Oncology | RTOG Trials | Randomized Trials
General Supportive Care for Radiation Therapy
# Radiation Oncology/Supportive care/Esophagitis

* Front Page: Radiation Oncology | RTOG Trials | Randomized Trials
Esophageal Toxicity Management

## Toxicity and Dosimetry

* Please see the Esophagus Toxicity section for information about toxicity grading and dosimetric considerations

## Treatment Overview

* Symptomatic relief
** Topical anesthetics (e.g. viscous lidocaine)
** NSAID analgesics
** Narcotic analgesics
** Ca++ blocker if spasm a component
** Proton pump inhibitor if GERD a component
* Nutritional support
** IV fluids
** G-tube feeding
** TPN
* Sucralfate may be helpful, but clinical trials inconclusive

## Prevention
### Sucralfate

* NCCTG (1993-1994) -- Sucralfate suspension vs placebo
** Randomized. 97/100 patients undergoing mediastinal RT. Arm 1) Sucralfate suspension 1g/30 ml QID during and for 2 weeks after RT vs. Arm 2) placebo
** 1997 PMID 9060568 -- "Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis." (McGinnis WL, J Clin Oncol. 1997 Mar;15(3):1239-43.)
*** Outcome: No difference in RTOG esophagitis score or self-reported questionnaire scores
*** Toxicity: GI toxicity sucralfate 58% vs. placebo 14% (SS); medication stopped 40% vs. 4% (SS)
*** Conclusion: No benefit for oral sucralfate solutions, with significant side effects

### Amifostine

* Greece Multicenter (1997-1999) -- amifostine vs control
** Randomized. 97 patients with advanced lung CA, undergoing definitive RT 55-60 Gy. No concurrent chemotherapy. Arm 1) amifostine 340 mg/m2 QD 15 min prior to RT vs. Arm 2) control
** 2001 PMID 11704311 -- "Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer." (Antonadou D, Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):915-22.)
*** Pneumonitis: Grade 2+ amifostine 9% vs. control 43% (SS); Grade 2+ lung damage 16% vs. 49% (SS); 6-month rate of fibrosis 28% vs. 53% (SS)
*** Esophagitis: Grade 2+ amifostine 4% vs. 42% (SS)
*** Outcome: 2-month PR/CR amifostine 75% vs. control 76% (NS)
*** Conclusion: Amifostine reduces pneumonitis, lung fibrosis, and esophagitis without compromising efficacy

### Glutamine

* Barcelona; 2007 (Spain) PMID 17531398 -- "Prevention of radiochemotherapy-induced esophagitis with glutamine: results of a pilot study." (Algara M, Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):342-9. Epub 2007 May 24.)
** Prospective. 75 patients with lung CA. Prophylactic glutamine powder 10g TID. RT 65-70 Gy
** Outcome: no esophagitis in 49% of concurrent chemo-RT and 73% of sequential chemo-RT patients
** Dosimetry: Grade 2+ esophagitis if V50 <=30% risk 22% vs. V50 >30% risk 71% (SS)
** Conclusion: Oral glutamine may have role in prevention of esophageal complications
# Radiation Oncology/Supportive care/Neurologic symptoms

* Front Page: Radiation Oncology | RTOG Trials | Randomized Trials

## Radiation brain injury

For brain tumor patients after brain irradiation:
* Introduction
** Radiation induced injury is manifested by fatigue, confusion, and cognitive impairment.
** Imaging studies show demyelination, decreased cerebral perfusion, decreased cerebral metabolism, and decreased cerebral N-acetyl aspartate (ref: PMID 16549835)
* Wake Forest; 2007 PMID 17869448 -- "A Phase III, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial of d-threo-methylphenidate HCl in Brain Tumor Patients Receiving Radiation Therapy." (Butler JM Jr, Int J Radiat Oncol Biol Phys. 2007 Sep 13; [Epub ahead of print])
** Randomized. 68 patients with primary or metastatic brain tumors. Arm 1) prophylactic d-MPH 5mg BID -> 15mg BID vs. Arm 2) observation. Outcome measure QOL and cognitive function
** Outcome: No difference in fatigue, QOL, or cognitive function
** Conclusion: Prophylactic d-MPH not beneficial in brain tumor patients
* Donepezil (Aricept) - acetylcholinesterase inhibitor
** Wake Forest, 2006 (2001-2003) - PMID 16549835 — "Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life." Shaw EG et al. J Clin Oncol. 2006 Mar 20;24(9):1415-20.
*** Phase II. 5 mg/d x 6 weeks, then 10 mg/d x 18 weeks. Total of 24 weeks, followed by washout. Evaluated by multiple cognitive tests
*** 35 pts receiving partial or whole brain RT > 6 months before the study; KPS >= 70%; no evidence of tumor progression; steroids allowed but had to be stable or decreasing dose.
*** 24 of 35 pts remained on study for 24 weeks. Significant improvement from baseline to 24 weeks for attention/concentration, verbal memory, and figural memory and a trend for verbal fluency. Improvement in confused mood and a trend for fatigue and anger. Improved health-related QOL. 48% of pts chose to continue taking donepezil after the 24 weeks.

## Driving impairment

Imposing driving restrictions on patients with brain tumors or neurologic symptoms from cancer
* See Official guidelines
* U.Wisconsin, 2011 PMID 20972603 -- "Current practices of driving restriction implementation for patients with brain tumors." (Thomas S, J Neurooncol. 2011 Jul;103(3):641-7.)
** Survey of U.S. practitioners
** "This survey highlights the lack of consensus regarding the responsibilities of physicians treating brain tumor patients in designing and enforcing driving restrictions. We propose that a panel of experts generate driving restriction guidelines to be used in conjunction with objective testing of motor and sensory impairment. These would aid practitioners in developing individualized driving restrictions for every brain tumor patient."

## Review

* Wake Forest; 2006 PMID 17032563 -- "Managing the cognitive effects of brain tumor radiation therapy." (Butler JM, Curr Treat Options Oncol. 2006 Nov;7(6):517-23.)
# Radiation Oncology/Supportive care/Guidelines

* Front Page: Radiation Oncology | RTOG Trials | Randomized Trials
Supportive Care Guidelines
Multinational Association For Supportive Care in Cancer (MASCC)
* Antiemetic Guidelines
** Chemotherapy Anti-Emesis Tool
* Mucositis Guidelines
** Cancer manuscript link
# Reaktor/Synthesis/Physical modelling
## Physical modelling in general

* Physical modelling at Wikipedia
* Musical Physical Modelling
* Physical Modelling Synthesis by Nicky Hind

## Examples of Physical Modelling Instruments for Reaktor

* Steam Pipe
* ReZone
* Accoustring
* Twanger
* Silverwood
* Prepared Guitar
* Cathedral Flutes
* Geetar
* Whack It

## Classic hardware Physical Modeling synthesis instruments

* Yamaha VL1
* Yamaha VL70-m
* Korg EXB-MOSS card for Triton & Karma; under license from Stanford U. & Yamaha
# Reaktor/Tutorials
## Basics

* Terminology
* Modules, Macros, Instruments, Ensembles

## Tutorials

* Reaktor as effects processor
* matsc:s basic Reaktor tutorial- Many tutorials here
* Where are the values?
* Variable Slope - how to create an envelope with a variable slope (a curve).
* Applied algebra for Reaktor users
* Use of IC Send module with any sequencer
* Converting Gate to Edge
* Rounding a number
* Implementing Aftertouch
* Creating a Hold button
* Implementing Pitchbend
* Clavia Nord Lead - Building Tutorial
* Reaktor Diary - A blog about instrument building

## Clocks and sequencing

* Basic Clock Demo
* Event Table Tutorial

## Best tips from user forum

* Scaling values (or click here for a better explanation on this wiki)
* How to elliminate DC offset?
* Importing Akai Mixed-Mode CDs
* How to stop LFO at its highest value?
* How to record sequenced track in Cubase to audio?
* After making a copy of a table, both tables change value when one is edited
* Discussion about event processing
* Saturation issues (this link doesn't actually offer a solution!)
* Fine-tuning of knob values

## Requests

* Please submit requests for tutorials here
# Reaktor/Synthesis/Wavetable
## Wavetable synthesis in general

* Synthesizer at Wikipedia
* Wavetable synthesis at Wikipedia
* A Tutorial on MIDI and Wavetable Music Synthesis by Jim Heckroth

## Examples of Wavetable synthesis Instruments for Reaktor

* NanoWave - available with Reaktor 3 Premium Library

## Classic hardware wavetable synthesis instruments

* PPG Wave - now available as VST plugin from Steinberg
# Reaktor/Tutorials/Hold switch
## How to insert a Hold Switch into a synth

Sometimes, it is useful to hold a note or chord indefinitely without continuously holding down keys or pushing the sustain pedal. You can achieve that with a hold switch that can be implemented as follows:
1. insert a button at the instrument level (toggle type, range 0-1)
2. assign it to MIDI controller 66 (no connections are necessary)
Notes
- make sure that the instrument properties allow for a hold control, and that it is assigned to cc #66
- check if the button's MIDI in is activated
- don't copy + paste the button from another instrument, it won't work!!
# Reaktor/Tutorials/Converting Gate to Edge

Converting a gate signal, for example a midi gate or the mouse button output of a mouse area, to a trigger signal can be used to trigger an envelope, to store a value into a snap value, etc...
This can be achieved using a stepfilter with a threshold of 0.
Another way to achieve this is to use a Separator combined with a stepfilter. This can be useful to separate the two-levels of the gate signal into separate signals.
# Reaktor/Tutorials/Pitchbend
## How to insert a Pitchbend controller into a synth

Insert a PitchBend MIDI Module into the instrument and connect it via a "+" module in parallel to the MIDI NotePitch module.
To add Bend Range, create a fader,and call it "Bend Range". Set the Min value to -12, the Max to 12, and the step size to 1. Connect a PitchBend MIDI module and the Bend Range fader via a "*" module (Multiply). Now connect the output of the "*" module in parallel to the MIDI NotePitch module via a "+" module.
# Reaktor/Synthesis/Subtractive
## Substractive synthesis in general

* Synthesizer at Wikipedia
* Subtractive synthesis at Wikipedia
* Introduction to Subtractive Synthesis by Mister Bill
# Reaktor/Tutorials/Aftertouch
## How to implement a generic aftertouch

1. insert a Channel AT or Poly AT module into your instrument
2. insert a IC Send module, connect it to the AT module you just created
3. switch the IC Send module to "Always Active"
4. switch the IC Send module to "Visible"
Notes
The IC Send module gives you a list where to route the aftertouch to. From this list, you can select an arbitrary controller to receive the aftertouch signals. Note, however, that AT signals normally range from 0 to 1 and thus may have to be adjusted to appropriately control a specific parameter of your instrument that has a different range.